Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06815237 · ClinicalTrials.gov registry record · Phase 2

Effects Ketone Supplement and Alcohol on Brain Metabolism

A Phase 2 study of Alcohol Drinking and MRI, sponsored by University of Pennsylvania.

Recruiting
Registry status
Phase 2
Development phase
20
Enrollment target
1
Study location

NCT06815237 is a Phase 2 study of Alcohol Drinking and MRI that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 20 participants, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06815237, a Phase 2 study of Alcohol Drinking and MRI, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
Phase 2
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The research study is being conducted to better understand the effects of ketones and alcohol on brain functioning and brain metabolism. Participants will be asked to undergo three identical MRI visits after three single-dose interventions: (1) drink a ketone supplement drink, (2) drink an alcoholic beverage, (3) no intervention. These interventions will be randomly assigned (meaning everyone receives all 3 interventions, but in different orders).

Interventions

  • DIETARY_SUPPLEMENT Kenetik
  • OTHER Alcohol beverage

Study Locations (1)

Pennsylvania

  • Center for Studies of Addiction - Philadelphia

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-05-13
Est. Completion 2029-02
Phase Phase 2

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT06815237

The ClinicalTrials.gov registry entry for NCT06815237 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (97% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 2 interventions - of which Kenetik is the first listed.

NCT06815237 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06815237 about?

NCT06815237 is a clinical study titled "Effects Ketone Supplement and Alcohol on Brain Metabolism". The research study is being conducted to better understand the effects of ketones and alcohol on brain functioning and brain metabolism. Participants will be asked to undergo three identical MRI visits after three single-dose interventions: (1) drink a ketone supplement drink, (2) drink an alcoholic...

What is the current status of trial NCT06815237?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2025-05-13. Estimated completion is 2029-02.

What conditions does trial NCT06815237 study?

This clinical trial studies the following conditions: Alcohol Drinking, MRI, Ketosis.

What interventions are being tested in trial NCT06815237?

The interventions under investigation include: Kenetik (DIETARY_SUPPLEMENT), Alcohol beverage (OTHER).

Who is sponsoring clinical trial NCT06815237?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06815237 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Drinking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.